GeoVax Labs (GOVX) Gains Pre-Market Momentum With Critical Vaccine Trial Award
GeoVax Labs, Inc. (NASDAQ: GOVX) shares have observed a notable rise following the award of a substantial trial contract. During the pre-market session, GOVX shares
GeoVax Labs, Inc. (NASDAQ: GOVX) shares have observed a notable rise following the award of a substantial trial contract. During the pre-market session, GOVX shares
Sundial Growers Inc. (SNDL) stock soared 1.72% to $0.5088 in the pre-market trading after declaring $50 million prepayment on senior secured non-revolving term credit facility.
Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.